Patents by Inventor Joe Buechler

Joe Buechler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid encoding anti-IL13 human antibodies
    Patent number: 9650438
    Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: May 16, 2017
    Assignee: Novartis AG
    Inventors: Emma Michelle Campbell, Sofia Parveen, Joe Buechler, Gunars Valkirs
  • Nucleic Acid Encoding Anti-IL13 Human Antibodies
    Publication number: 20170101467
    Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Application
    Filed: February 24, 2015
    Publication date: April 13, 2017
    Applicant: Novartis AG
    Inventors: Emma Michelle Campbell, Sofia Parveen, Joe Buechler, Gunars Valkirs
  • Methods of Using Anti-IL13 Human Antibodies
    Publication number: 20150259411
    Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Application
    Filed: February 24, 2015
    Publication date: September 17, 2015
    Applicant: Novartis AG
    Inventors: Emma Michelle Campbell, Sofia Parveen, Joe Buechler, Gunars Valkirs
  • Methods of using anti-IL13 human antibodies
    Patent number: 8992916
    Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: March 31, 2015
    Assignee: Novartis AG
    Inventors: Emma Michelle Campbell, Sofia Parveen, Joe Buechler, Gunars Valkirs
  • Anti-IL 13 Human Antibodies
    Publication number: 20140023660
    Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Application
    Filed: October 2, 2013
    Publication date: January 23, 2014
    Applicant: NOVARTIS AG
    Inventors: Emma Michelle CAMPBELL, Sofia PARVEEN, Joe BUECHLER, Gunars VALKIRS
  • Method of using anti-IL-13 antibodies
    Patent number: 8580260
    Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: November 12, 2013
    Assignee: Novartis AG
    Inventors: Emma Michelle Campbell, Sofia Parveen, Joe Buechler, Gunars Valkirs
  • Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
    Patent number: 8476040
    Abstract: The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: July 2, 2013
    Assignee: Xoma Technology Ltd.
    Inventors: Jeff Gray, Joe Buechler, Uday Kumar Veeramallu
  • Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
    Publication number: 20110224102
    Abstract: The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.
    Type: Application
    Filed: May 20, 2011
    Publication date: September 15, 2011
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Jeff Gray, Joe Buechler, Uday Kumar Veeramallu
  • Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
    Patent number: 7977068
    Abstract: The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: July 12, 2011
    Assignee: XOMA Technology Ltd.
    Inventors: Jeff Gray, Joe Buechler, Uday Kumar Veeramallu
  • Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
    Patent number: 7972811
    Abstract: The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.
    Type: Grant
    Filed: January 28, 2008
    Date of Patent: July 5, 2011
    Assignee: XOMA Technology Ltd.
    Inventors: Jeff Gray, Joe Buechler, Uday Kumar Veeramallu
  • ANTI-IL 13 HUMAN ANTIBODIES
    Publication number: 20110091458
    Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Application
    Filed: December 22, 2010
    Publication date: April 21, 2011
    Inventors: Emma CAMPBELL, Sofia Parveen, Joe Buechler, Gunars Valkirs
  • Anti-IL13 human antibodies
    Patent number: 7910708
    Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Grant
    Filed: October 19, 2006
    Date of Patent: March 22, 2011
    Assignee: Novartis AG
    Inventors: Emma Campbell, Sofia Parveen, Joe Buechler, Gunars Valkirs
  • High sensitivity secretagogin assays and their uses for diagnosis and/or prognosis
    Publication number: 20100267060
    Abstract: The present invention relates to methods and compositions for measuring secretagogin in test samples, particularly patient samples. Preferred methods comprise performing a sandwich immunoassay, most preferably using a pair of monoclonal antibodies that bind to secretagogin.
    Type: Application
    Filed: January 17, 2007
    Publication date: October 21, 2010
    Applicant: Biosite Incorporated
    Inventors: Joe Buechler, Kevin Nakamura
  • Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
    Publication number: 20100009857
    Abstract: The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.
    Type: Application
    Filed: January 28, 2008
    Publication date: January 14, 2010
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Jeff Gray, Joe Buechler, Uday Kumar Veeramallu
  • Anti-Il13 Human Antibodies
    Publication number: 20080267959
    Abstract: The present invention relates to human anti-IL-13 binding molecules, particularly antibodies, and to methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Application
    Filed: October 19, 2006
    Publication date: October 30, 2008
    Inventors: Emma Campbell, Sofia Parveen, Joe Buechler, Gunars Valkirs
  • Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
    Publication number: 20080214411
    Abstract: The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.
    Type: Application
    Filed: January 25, 2008
    Publication date: September 4, 2008
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: Jeff Gray, Joe Buechler, Uday Kumar Veeramallu
  • Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
    Patent number: 7396661
    Abstract: The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: July 8, 2008
    Assignee: XOMA Technology Ltd.
    Inventors: Jeff Gray, Joe Buechler, Uday Kumar Veeramallu
  • HUMAN ANTIBODIES AS DETECTION REAGENTS
    Publication number: 20080039338
    Abstract: The invention provides in vitro methods of detection using human antibodies. The methods are particularly useful for analyzing human samples containing HAMA or heterophilic antibodies. A human antibody can bind to an analyte in such samples without binding to HAMA or heterophilic antibodies present in the sample. The methods can be effected using a sandwich format among others.
    Type: Application
    Filed: March 12, 2007
    Publication date: February 14, 2008
    Applicants: Biosite, Inc., Medarex, Inc.
    Inventors: Joe Buechler, Gunars Valkirs, Jeff Gray, Nils Lonberg
  • LATENT PROTEIN C ASSAYS AND THEIR USES FOR DIAGNOSIS AND/OR PROGNOSIS IN SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES
    Publication number: 20070172906
    Abstract: The present invention relates to methods and compositions for measuring latent protein C in test samples, particularly patient samples. The methods and compositions described are sensitive for latent protein C, relative to activated protein C.
    Type: Application
    Filed: December 21, 2006
    Publication date: July 26, 2007
    Applicant: Biosite Incorporated
    Inventors: Gunars Valkirs, Joe Buechler
  • Human antibodies
    Publication number: 20070111259
    Abstract: The invention uses the power of display selection methods to screen libraries of human immunoglobulin genes from nonhuman transgenic animals expressing human immunoglobulins. Such screening produces unlimited numbers of high affinity human antibodies to any target of interest.
    Type: Application
    Filed: September 13, 2006
    Publication date: May 17, 2007
    Applicant: Medarex, Inc.
    Inventors: Joe Buechler, Gunars Valkirs, Jeff Gray, Nils Lonberg